Introduction
Tuberin, encoded by the tuberous sclerosis complex 2 ( tsc2 ) gene, is an important tumor suppressor protein.
The tsc2 gene was identified through its association with a familial autosomal multisystem disorder known as tuberous sclerosis complex (TSC) with a prevalence of 1 in 6,000-10,000 births [1, 2] . Over the past decade, considerable progress has been made in understanding the molecular genetics of TSC, which is highlighted by the identification of tsc1 and tsc2 [3, 4] ; mutations in either tsc1 or tsc2 cause the disease. In vivo, tuberin and hamartin ( tsc1 product) form heteromers and the hamartin-tuberin interaction appears to be important for the stability of each protein [5] . Human tsc2 gene is located on chromosome 16 (16p13.3) and its 198-kDa product tuberin is ubiquitously expressed [1] . Tuberin can be found at multiple sites within the cell including the cytosol, microsomes, cytoskeletal components and nucleus [6] . Whilst some studies have suggested that Akt activity influences tuberin levels [7, 8] , other studies were unable to observe an affect [9, 10] . Consistent with the latter, mitogenic stimulation induces Akt activity, whereas tuberin protein amounts remain constant [11, 12] . The Akt-mediated phosphorylation of tuberin at Ser 939 is thought to be crucial for the regulation of tuberin localization. Tuberin is thought to be localized to the mitochondria and also translocated to the nucleus in the late G1 phase of cell mitosis [13] . Upon activation of Akt and phosphorylation of tuberin, it is thought that tuberin is localized in the cytosol, where it is bound to 14-3-3 and physically sequestered away from hamartin, unable to form a stable heteromer [14] . Tuberin is highly evolutionarily conserved and shows a high degree of similarity between species, ranging from fission yeast Schizosaccharomyces pombe , fruit fly Drosophila , Japanese pufferfish Fugu rubripes , rat, mouse, to human [15] [16] [17] [18] [19] [20] .
The critical importance of the tsc2 gene for maintaining normal biological functions could be inferred by the manifestations of the disease. Patients with TSC develop hamartomas and benign tumors in the brain, heart and kidney, and they can exhibit cognitive defects, epilepsy and autism [4, [21] [22] [23] [24] . These manifestations illustrate the importance of tuberin signaling in the central nervous system. Furthermore, the tsc2 -/-null mice are embryonically lethal, demonstrating that tuberin is essential for development [25] . Until recently, it was unclear how tuberin exercised its functions as a tumor suppressor protein. Recent exciting discoveries have suggested a role for tuberin in modulating the activity of TOR (target of rapamycin), a central regulator of cell growth and proliferation [26] [27] [28] .
Apart from demonstrating the role of tuberin in the regulation of cell growth and proliferation, results from several laboratories over the past few years have provided new insights into how tuberin might affect cell survival, cell adhesion, cell morphology, cell migration, neuronal differentiation, regulation of cellular energy, post-Golgi transport, or protein trafficking in the cell [29] [30] [31] [32] [33] [34] [35] . A particularly interesting feature of tuberin is the presence of multiple serine, threonine and tyrosine phosphorylation sites [36, 37] , suggesting that the functional activity of tuberin could be potentially regulated by different signaling molecules. Furthermore, a previous study has demonstrated that tuberin is a component of lipid rafts [35] . Lipid rafts are enriched in molecules such as G protein-coupled receptors (GPCRs), G proteins, receptor tyrosine kinases (RTKs), Src family tyrosine kinases, protein kinase C, and nitric oxide synthase [38] . This further supports a scenario wherein tuberin is able to interact with various signaling molecules and affect their functions. Akt-dependent phosphorylation of tuberin has been identified as an important step which regulates mammalian TOR (mTOR) and p70 S6 kinase activities in response to activation of RTK by insulin [26, 37] . Apart from insulin, other RTK agonists have the ability to regulate tuberin activity. Is has also become increasingly apparent that, like RTKs, GPCRs and G proteins are involved in the regulation of cell growth and survival [39, 40] . Many of these effects may be mediated by tuberin. Although much has been written regarding the molecular genetics of TSC, which is associated with the mutation in or loss of tsc2 gene, few reviews have addressed the mechanisms by which the function of tuberin can be regulated. The current review outlines our emerging understanding of extracellular stimuli-promoted tuberin regulation and the coordination of various stimulus-mediated effects by tuberin.
Regulation of Tuberin by RTKs
Growth factors regulate the tuberin activity by an elaborate mechanism initiated by RTK dimerization, autophosphorylation, and the sequential recruitment of the adaptor proteins, such as Grb2-associated binder 2 (Gab2) and Casitas B-lineage lymphoma (Cbl), that serve as the adaptors for phosphatidylinositol 3-kinase (PI3K). Recruited PI3K would in turn stimulate Akt phosphorylation and activation [41, 42] . Eventually, tuberin would be phosphorylated by activated Akt, disassociated from its binding partners and degraded via a proteasomal mechanism [29, 43] . The mechanisms by which Akt-mediated phosphorylation of tuberin that lead to the degradation and functional inactivation of tuberin remain unclear. Nevertheless, phosphorylation and inactivation of tuberin is required for activation of mTOR and p70 S6 kinase as well as inhibition of eukaryotic initiation factor 4E binding protein 1 (4E-BP1, an inhibitor of translation) [9, 44, 45] . Although Akt was the first kinase known to phosphorylate and inactivate tuberin upon insulin or growth factor stimulation [9, 37, 45] , other kinases have also been found to regulate the activity of tuberin ( fig. 1 ). These kinases include MAPK-activated protein kinase 2 (MK2) [46] , p90 ribosomal S6 kinase 1 (p90 RSK1) [47] , AMP kinase (AMPK) [48] and extracellular signal-regulated kinase (ERK) [49] .
The phosphorylation of tuberin by Akt and MK2 promotes the binding of tuberin with 14-3-3 proteins. 14-3-3 proteins are members of a group of proteins that specifically interact with phosphorylated proteins, facilitating the phosphorylation-dependent control of protein activity [50] . Detection of a ternary complex of tuberin, hamartin and 14-3-3 suggests that the tuberin-14-3-3 interaction is compatible with tuberin-hamartin binding and that 14-3-3 proteins interact with the tuberin-hamartin complex [51, 52] . A possible function of the interaction between 14-3-3 proteins and phosphorylated tuberin is to inhibit the formation of tuberin-hamartin complex, in order to decrease the stability of tuberin and release of the activated mTOR [51] . Apart from MK2, ERKs and p90 RSK1 were also found to be able to hinder the tuberinhamartin complex formation and attenuate tuberin activity by inducing tuberin phosphorylation [47, 49] . Other than to hinder the tuberin-hamartin complex formation, phosphorylation of tuberin at Ser 1798 by p90 RSK1 is important for PMA-induced stimulation of p70S6K. This effect is additive to the phosphorylation by Akt at Ser 939 and Thr 1462 [48] . It is interesting to note that tuberin has been reported as an upstream regulator of the ERK pathway. Loss of tuberin correlates with high ERK activity [53] and significant phosphorylation of ERKs [54] . Restoration of tuberin in tsc2 -/-cells remarkably decreased B-Raf activity [55] , further demonstrating the negative role of tuberin in the activation of ERKs. The association of tuberin activity to B-Raf and ERK is unclear. Nonetheless, it has been proposed that the Rap1 GTPase activating protein (GAP) activity of tuberin may be involved [55] . Moreover, it should be noted that, as mentioned before, ERKs are able to decrease tuberin activity. Taken together, these observations suggest a positive feedback loop from decreasing activity of tuberin to activation of ERKs. All these phosphorylation events inactivate tuberin and positively regulate the mTOR signaling pathway. In contrast, tuberin was shown to be activated by AMPK phosphorylation at Thr 1227 and Ser 1345 under energy-deprived circumstances [31] . Activated tuberin controls the cell size, thus protecting the cells from apoptosis under energy deprivation. An increasing number of kinases (Akt, ERKs, p90 RSK1, AMPK, MK2) directly upstream of tuberin have been identified, and almost all of them are negative regulators of tuberin. Under a normal physiological system, these kinases may be working in a cooperative manner to produce an additive effect on tuberin regulation.
The first agonist of RTK identified to induce tuberin regulation is insulin [56, 57] . The mechanism by which insulin and its family members, including insulin-like growth factor (IGF)-I and IGF-II, induces tuberin regulation has been extensively studied. For the insulin family members, insulin receptor substrate (IRS) proteins play a critical role in regulating tuberin. After binding of the insulin and IGF to their receptors, IRS proteins are phosphorylated by RTKs which then act as the binding sites for the recruitment of PI3K. Furthermore, a negative feedback loop from p70 S6 kinase to IRS proteins is responsible for the attenuation of Akt activity in tuberinnull cells [58, 59] . A similar negative feedback loop involving p70 S6 kinase repression of Akt activation has also been described in Drosophila [60] . This negative feedback program balances the activities between Akt and p70 S6 kinase in order to prevent the cell from inappropriate activation of the mTOR/p70 S6 kinase pathway. A recent study has provided experimental evidence to show that tuberin plays an inhibitory role in this negative feedback loop [61] . In order to maintain insulin signaling to PI3K, tuberin-hamartin complex indirectly induces IRS-1 gene expression and promotes phosphorylation of IRS-1 by restraining the activity of p70 S6 kinase. Both of these two mechanisms, regulation of IRS-1 expression and phosphorylation, act in the same manner toward insulin-PI3K activation ( fig. 2 ). This is consistent with the observations in tsc2 -/-cells where p70 S6 kinase is hyperactive and PI3K is defective [59, 62, 63] and inactivation of tuberin-hamartin complex leads to constitutive p70 S6 kinase activity [64, 65] . In other words, by suppressing the negative feedback loop from p70 S6 kinase to IRS proteins, tuberin is a key positive regulator of PI3K signaling.
Although IRS proteins are the scaffolding proteins for the receptors of insulin family, recruitment of IRS by other RTKs has also been demonstrated. For instance, nerve growth factor (NGF)-activated TrkA receptor is able to recruit IRS proteins in order to stimulate PI3K activity [66] . Therefore, it is likely that NGF is able to affect the activity and phosphorylation level of tuberin. Consistent with this expectation, NGF has indeed been shown to stimulate tuberin phosphorylation through the PI3K/Akt pathway [29] ( fig. 3 ) . Besides the participation of PI3K/ Akt pathway, it is interesting to note that free G ␤ ␥ complexes released from G i/o proteins are apparently involved in NGF-induced tuberin phosphorylation. G ␤ ␥ stimulates tuberin phosphorylation via the PI3K/Akt pathway. It has also been demonstrated that NGF can utilize G i/o proteins to regulate ERKs [67] . The mechanism by which TrkA receptors induce G ␤ ␥ release remains unknown. There are scattered reports on growth factor receptors, such as insulin RTK, interacting with G proteins [68] [69] [70] [71] . Furthermore, IGF-I has been shown to activate G i to release G ␤ ␥ subunits [72] . These findings further reveal and strengthen the important connection between G i/o protein signaling and NGF-induced tuberin regulation. [67, 73] ( fig. 3 ) .
Recruitment of different scaffolding adaptor components to the activated TrkA and the EGF receptor complex may provide an explanation for the involvement of G i/o signaling in NGF-regulated, but not in EGF-induced, tuberin phosphorylation. EGF rapidly induces marked dephosphorylation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) and the C3G/CrkL/ Shp2 complex is recruited to the EGF receptor via the adaptor Cbl [74, 75] . In contrast to EGF treatment, C3G is persistently tyrosine phosphorylated after NGF treatment. NGF induces the binding of C3G/CrkL/Shp2 to Gab2 and TrkA [75] . In other words, TrkA is able to recruit Gab2 to form a complex, whereas the EGF receptor binds with another adaptor protein Cbl. It is interesting that although both Cbl and Gab2 serve as PI3K adaptors, only Gab2 can be phosphorylated and regulated by the G i -coupled N-formyl-methionyl-leucyl-phenylalanine receptor [76] . Thus, it seems that Gab2 may serve as a bridge to link TrkA, G i/o proteins, and PI3K. Although not all RTKs can induce G i/o protein to release G ␤ ␥ , as we learned from the example of EGF, G proteins and their coupled receptors may play an important role in the regulation of tuberin. While NGF can either directly or indirectly affect the activity of G proteins, GPCRs are primarily responsible for G protein activation. In the next section, we will review how G proteins and their receptors regulate tuberin activity.
Mechanisms of Tuberin Regulation by GPCRs
GPCRs constitute a large family of single polypeptide chain receptors, with seven transmembrane ␣ -helices composed predominantly of hydrophobic residues looping between the extracellular and intracellular regions. A diverse array of external stimuli, including neurotransmitters, hormones, phospholipids, photons, odorants, taste ligands and mitogens, bind to specific GPCRs, which subsequently interact with respective G proteins to induce downstream signaling [77] . Many isoforms of the different G protein subunits have been cloned and classified according to the subtype of their G ␣ subunit into four groups: G s , G i , G q/11 and G 12/13 . Under basal conditions, G proteins exist as heterotrimers with GDP bound to the G ␣ . Agonist-stimulated receptor promotes the release of GDP, the binding of GTP, and the dissociation of GTP-G ␣ from the G ␤ ␥ complex. Both G ␣ and G ␤ ␥ subunits can regulate downstream effectors in a selective manner that can be independent, synergistic, or antagonistic. Endogenous GTPase activity of the G ␣ subunit terminates its ability to regulate effector activity and leads to GDP-G ␣ reassociation with G ␤ ␥ [77] .
The G protein family that has been studied in most detail with respect to the regulation of tuberin activity is G i . To reveal the involvement of G i/o proteins in a particular signaling pathway, pertussis toxin (PTX) is an indispensable tool since the toxin catalyzes the ADP-ribosylation of G i/o proteins and abolish their ability to become activated [78] . As mentioned in the above section, it has been demonstrated that PTX-sensitive G i family members are involved in NGF-regulated activation of Akt and phosphorylation of tuberin [29, 73] . Moreover, there have been several recent reports of GPCR-mediated activation of Akt. The majority of these responses involves PI3K and is inhibited by PTX, suggesting a requirement for G i/o protein activity [79] [80] [81] [82] [83] . In addition, a previous study has reported that tuberin and G i -coupled somatostatin type 5 receptor (SSTR5) genes form a synteny group in the Fugu genome [84] . These studies serve to illustrate the important role of G i/o -mediated signaling in tuberin regulation. Not surprisingly, a diverse range of G i -coupled receptors are capable of regulating tuberin. For example, all three opioid receptor subtypes ( ␦ , , ), ␣ 2 -adrenoceptor, and muscarinic M 4 receptor are capable of inducing the phosphorylation of tuberin in both transfected and native cellular models [29, 30, 73] . Tuberin is rapidly phosphorylated in response to the G i -coupled receptor agonists. Similar to the RTK-induced tuberin phosphorylation, G i -coupled receptor-mediated tuberin phosphorylation is sensitive to wortmannin (a PI3K inhibitor), indicating that PI3K/Akt is the major signaling pathway involved in G i -coupled receptor-induced tuberin phosphorylation. These observations are in line with the other reports which showed that G i -coupled receptors are able to activate the PI3K/Akt pathway [85] [86] [87] . Moreover, like the NGF receptor, G i -coupled receptors affect tuberin activity through the release of G ␤ ␥ complexes. The G ␤ ␥ complex rather than the G ␣ i/o subunit appears to serve as the major signal carrier in G i -coupled receptor-induced tuberin regulation [29] ( fig. 3 ) .
Although both NGF and agonists for G i -coupled receptors are able to stimulate PI3K/Akt pathway to regulate tuberin phosphorylation, the temporal profile is rather different between the two stimuli. Agonists for G icoupled receptors are only able to stimulate tuberin 222 phosphorylation transiently and cannot affect the total tuberin protein level [29] . In contrast, NGF can maintain tuberin in a phosphorylated state persistently and induce tuberin degradation [29] . It was proposed that NGF may induce mTOR activity to promote survival of neuronal cells by degrading tuberin [29] . This may account for why some agonists of G i -coupled receptors, such as opioid and ␦ 2 opioid, are only able to transiently prevent cell death [85] , while most of the trophic factors can promote cell survival in a prolonged manner [88, 89] . Although most GPCRs fail to acutely regulate total tuberin protein level, a study has demonstrated that prostaglandin (PG) E 2 can down-regulate tsc2 gene expression via its corresponding GPCR upon chronic stimulation of human endometrial adenocarcinoma cells [90] . In agreement with this finding, numerous studies have revealed the pro-survival ability of PGE 2 [91] [92] [93] .
Given the importance of tuberin in the regulation of cell survival, growth and proliferation, these observations imply that tuberin may be one of the important signaling molecules involved in GPCR-exerted effects. This is especially true for neuropeptides, which are known to regulate cell proliferation, neuronal survival, and antiapoptotic pathways [85, 94, 95] . Although survival is best predicted by coupling to G i pathways that regulate PI3K and Akt, other signals generated through different G protein pathways are also implicated. For example, the ability of lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) to stimulate G i , G q , and G 12/13 pathways allow their corresponding receptors to support cell survival and proliferation [39] , which means that G q -or G 12/13 -coupled receptors are probably able to affect tuberin regulation ( fig. 3 ) .
There are several reports of G q -coupled receptors stimulating Akt, PI3K, or both [96] [97] [98] . Generally, G q proteins stimulate phospholipase C (PLC) ␤ isoform to induce Ca 2+ mobilization, which in turn regulates Ca 2+ -mediated effectors such as calmodulin (CaM). CaM is a well-defined mediator of a variety of intracellular signaling pathways and its activities have been shown to be contingent upon the binding of Ca 2+ [99, 100] . A binding site for CaM is present in the carboxyl terminus of tuberin [101] . The importance of CaM in tuberin signaling has also been suggested in a study which demonstrated that tuberin is able to regulate the gene expression of CaM [102] . These findings strongly suggest that G q -mediated Ca 2+ signaling is able to regulate the activity of tuberin ( fig. 2 ). There are experimental findings supporting that activated G q -coupled ␣ 1 -adrenergic receptor can stimulate tuberin phosphorylation to activate protein synthesis [103] . However, activated G q proteins have also been shown to inhibit Akt kinase activity [104] . More recently, several reports have demonstrated the inhibitory ability of G q -coupled receptors on Akt activity. For instance, neurotensin receptor-1, which is known to promiscuously couple to G s , G i and G q [105] [106] [107] , antagonizes EGFand insulin-stimulated Akt activation via G q signaling [108] . Likewise, luteinizing hormone-releasing hormone receptor strongly diminishes the anti-apoptotic effect of IGF-1 through inhibition of Akt activation. Our recent experimental results also demonstrated that other activated ␣ subunits of the G q family (G ␣ 11 , G ␣ 14 , and G ␣ 16 ) can attenuate basal and EGF-induced Akt activities and the phosphorylation of tuberin in a PLC ␤ -and Ca 2+ mobilization-independent manner [109] . In agreement, a number of recent studies have shown that the pro-apoptotic effect of G q/11 is neither dependent on PLC ␤ activity [110] nor on the elevation of intracellular calcium [111] . Hence, there has to be an alternative pathway for G q/11 to inhibit Akt which is independent of PLC ␤ and calcium signaling. One of the possible mechanisms is that G ␣ q/11 may activate protein tyrosine phosphatases which then dephosphorylate the IRS-1 and result in the inhibition of Akt through PI3K [104, 112] ( fig. 3 ) .
The remaining question is whether other G proteins, especially G 12/13 , could affect tuberin activity. Some of our current experimental data demonstrated that activated G 12 and G 13 are able to inhibit Akt and tuberin phosphorylation via RhoA [109] . Overexpression of the constitutively active G ␣ 12 and G ␣ 13 (G ␣ 12 QL and G ␣ 13 QL) is apparently sufficient to inhibit the EGF-induced Akt activation and tuberin phosphorylation in human embryonic kidney (HEK293) cells. Conversely, overexpression of the dominant negative mutant of RhoA blocked the G ␣ 12 QL-and G ␣ 13 QL-mediated inhibition. However, it appears that G 12/13 is involved in other Akt regulatory pathways. Data from a separate group has observed the ability of G ␣ 12 QL to stimulate the expression as well as the activation of platelet-derived growth factor receptor ␣ (PDGFR ␣ ) in NIH 3T3 and human astrocytoma 1321N1 cells [113] . The G ␣ 12 -PDGFR ␣ signaling axis was subsequently shown to activate the PI3-K/Akt signaling pathway via RhoA. Thus, it appears that G 12/13 is capable of directly inhibiting EGF-induced Akt and tuberin phosphorylation, as well as stimulating Akt and tuberin phosphorylation via PDGFR ␣ .
In addition to the pro-survival effect, tuberin is able to regulate translation and protein synthesis via inhibition of p70 S6 kinase. Alam et al. [114] [86, [115] [116] [117] , have also been shown to activate p70 S6 kinase in a wortmannin-sensitive manner and concomitantly stimulate Akt activity. By contrast, ␣ -adrenergic receptors stimulate Akt or p70 S6 kinase in a wortmannin-or LY294002 (another PI3K inhibitor)-insensitive manner [118] [119] [120] [121] , implying that, besides utilizing the PI3K pathway, some GPCRs may also regulate tuberin through other signaling pathways in order to regulate protein synthesis. Some of the identified kinases for tuberin, such as ERK and p90 RSK1, may also play a role in GPCR-induced tuberin regulation [121] ( fig. 3 ). Further explorations on the signaling pathways of GPCR-mediated tuberin regulation may represent one of the important directions for understanding the functions of tuberin.
Cooperation between RTK and GPCR
Cross-talk between GPCRs and RTKs is an incredibly complex process, and the exact signaling molecules involved are largely dependent on the cell type and the type of receptor being activated [122] . Transactivation of RTK such as EGF receptor by GPCRs has been recognized as an important event in mitogenic and pro-survival signaling [40, 123, 124] . EGF receptor activation apparently occurs via a plasma membrane-bound metalloproteinase, which is involved in the processing of EGF-like precursor molecules that are anchored to the outer surface of the plasma membrane [125] . Recently, some reports have also demonstrated that two GPCR ligands, adenosine and PACAP, can activate Trk receptor activity to increase the survival of neural cells through stimulation of Akt activity [126] [127] [128] . However, transactivation of TrkA or EGF receptor is not necessary for the stimulation of tuberin phosphorylation by G i -coupled opioid receptors and M 4 mAChR [30, 129] , indicating that different GPCRs may utilize disparate pathways to regulate their downstream effectors in order to carry out their biological functions.
While both GPCR and RTK are known to be able to affect tuberin regulation independently, what is the effect on tuberin if the two systems are simultaneously activated? Our recent study showed that co-activation of G icoupled M 4 muscarinic acetylcholine receptor (mAChR) and NGF receptor resulted in augmentation of Akt activity and tuberin phosphorylation in a G ␤ ␥ -and PI3K-dependent manner [30] . There is also evidence that suggests that activated M 4 mAChR is able to work together with NGF receptor to enhance cell survival. Sharing signaling components between RTKs and GPCRs may allow proximity-induced effects to generate responses more efficiently [130, 131] . Therefore, under normal physiological conditions, agonists for GPCRs or RTKs may not work alone. Fine-tuning of cellular responses may thus be achieved by balancing the activity levels of different sets of GPCRs and RTKs on the target cells ( fig. 3 ).
Conclusion
The identification of the phosphorylation sites of tuberin and the regulation of tuberin by RTKs a few years ago has initiated the intensive research on tuberin regulation. An increasing body of evidence has suggested that the functional activity of tuberin could be regulated by different signaling molecules and kinases, including PI3K, Akt, ERK, 14-3-3 proteins, and G proteins. Current data supports a model that, apart from RTKs, GPCRs are also able to regulate tuberin activity. Direct evidence has shown that G i/o -and G q -coupled receptors can regulate tuberin phosphorylation in a PI3K-dependent or -independent manner ( fig. 3 ) , while G 12/13 may have a dual role in regulating tuberin. The role of these G proteins in the regulation of tuberin activity should be explored in detail. Furthermore, the differential temporal profiles between RTK-and GPCR-regulated tuberin phosphorylation is also an interesting area to be investigated in the future. In the advent of new technological developments, the study of protein phosphorylation becomes increasingly accurate and rapid. In 2004 a group developed a protocol utilizing stable isotope-based quantitative mass spectrometry (MS) [132] . This protocol was able to simultaneously detect and quantify temporal changes in all of a protein's phosphorylation sites. Comparisons with traditional biochemical methods such as immunoblotting and activity assays validated the reliability of the MSbased method. These tools become increasingly important as we try to elucidate protein phosphorylation biochemical pathways. Tuberin is not only regulated by RTKs and GPCRs. A recent study has demonstrated that the forkhead transcription factor FoxO is capable of binding to tuberin [133] . FoxO binds to an adjacent region near the GAP domain, thus inhibiting the GAP activity towards Rheb. With the diverse array of tuberin regulators, future studies on the tuberin pathways will not only be interesting, but also challenging.
